Fig. 5.
Fig. 5. Constitutive expression of the N-terminal deletion mutant of TRAF3 blocks NF-κB activation following CD40 ligation. / (A) KMH2 transfectants expressing the full-length TRAF 3 construct (F-TRAF3) or the selectable marker alone (pSV2) were stimulated for 1 hour with CD40L. Nuclear extracts were analyzed for NF-κB DNA-binding activity EMSA. (B) KMH2 transfectants expressing the deletion mutant of TRAF3 (δ300TRAF3) or the selectable marker alone (pSV2neo) were stimulated for 1 hour with CD40L and nuclear extracts were analyzed for NF-κB DNA-binding activity. (C) Mean ± SE of densitometric results from 3 independent experiments as performed in panels A and B. Comp indicates competitor; ns, nonspecific; wt, wild type; mt, mutant; none, untransfected. Arrowheads indicate shifted oligonucleotide. The bars above the gels indicate the transfected construct contained in the KMH2 cells used in the experiment.

Constitutive expression of the N-terminal deletion mutant of TRAF3 blocks NF-κB activation following CD40 ligation.

(A) KMH2 transfectants expressing the full-length TRAF 3 construct (F-TRAF3) or the selectable marker alone (pSV2) were stimulated for 1 hour with CD40L. Nuclear extracts were analyzed for NF-κB DNA-binding activity EMSA. (B) KMH2 transfectants expressing the deletion mutant of TRAF3 (δ300TRAF3) or the selectable marker alone (pSV2neo) were stimulated for 1 hour with CD40L and nuclear extracts were analyzed for NF-κB DNA-binding activity. (C) Mean ± SE of densitometric results from 3 independent experiments as performed in panels A and B. Comp indicates competitor; ns, nonspecific; wt, wild type; mt, mutant; none, untransfected. Arrowheads indicate shifted oligonucleotide. The bars above the gels indicate the transfected construct contained in the KMH2 cells used in the experiment.

Close Modal

or Create an Account

Close Modal
Close Modal